Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Merck & Co
(NY:
MRK
)
130.75
+2.17 (+1.69%)
Streaming Delayed Price
Updated: 2:05 PM EDT, Aug 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Merck & Co
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
99
100
Next >
Peering Into Merck & Co's Recent Short Interest
↗
September 25, 2025
Merck & Co's (NYSE: MRK) short interest as a percent of float has risen 16.98% since its last report. According to exchange reported data, there are now 27.71 million shares sold short, which is 1.24%...
Via
Benzinga
Evaxion Stock Jumps A Whopping 43% Pre-Market – Here’s What Happened
↗
September 25, 2025
Via
Stocktwits
Merck & Co. Inc. (NYSE:MRK): A Prime Candidate for a Dependable Dividend Portfolio
↗
September 25, 2025
Merck & Co. (MRK) offers a solid 3.97% dividend yield with a strong history of growth. Its reliable payout is backed by excellent profitability and a healthy balance sheet, making it a top choice for...
Via
Chartmill
United Kingdom The Worst European Country For Drug Prices: Eli Lilly CEO
↗
September 24, 2025
Eli Lilly CEO Dave Ricks criticizes UK drug pricing and rebate rules as pharma giants scale back investments, warning of fewer new medicines.
Via
Benzinga
The Smartest Dividend Stock to Buy With $1,000 Right Now
↗
September 24, 2025
Drug makers are out of favor right now, but the industry will survive. Here's one company that stands out as an investment option.
Via
The Motley Fool
Topics
Intellectual Property
Price Over Earnings Overview: Merck & Co
↗
September 22, 2025
Via
Benzinga
Merck Says EMA Committee Adopted Two Positive Opinions For Expanding Use Of Cancer Drug Keytruda
↗
September 19, 2025
Via
Stocktwits
Should You Forget Pfizer and Buy These Unstoppable Stocks Instead?
↗
September 24, 2025
Pfizer has a huge yield right now, but it might make more sense for dividend investors to step down in yield to these two alternatives.
Via
The Motley Fool
Topics
Intellectual Property
3 Dividend Stocks Perfect for Millennial Investors
↗
September 24, 2025
All three of these names are not only built to last, they're being rebuilt to thrive for at least a few more decades.
Via
The Motley Fool
Topics
Economy
Intellectual Property
Retirement
The Magnificent 7 Boom Just Triggered A Dot-Com Era Warning
↗
September 23, 2025
The Magnificent Seven tech giants are now worth $21 trillion—8x more than top health care stocks, echoing dot-com bubble extremes.
Via
Benzinga
Trump Advises Parents To Split Vaccines, Delay Hepatitis B Shots Until Age 12: 'This Is Based On What I Feel'
↗
September 22, 2025
President Donald Trump on Monday offered advice on childhood vaccination schedules, encouraging parents to split up certain immunizations and delay certain others, in sharp contradiction to current...
Via
Benzinga
Topics
Government
Inflation's Lingering Shadow: Long-Term Expectations Rise Amidst Fed Rate Cuts
September 22, 2025
The financial markets are currently navigating a perplexing economic landscape where long-term inflation expectations are on the rise, even as the Federal Reserve initiates interest rate cuts. In...
Via
MarketMinute
Topics
Bonds
ETFs
Economy
FDA Clears Merck's One-Minute Cancer Shot
↗
September 22, 2025
FDA approves Merck's Keytruda Qlex injection for adults with solid tumors. Merck expects it to be available in the U.S. in September.
Via
Benzinga
Growth Titans: Eli Lilly's Weight-Loss Surge vs. Johnson & Johnson's Diversified Might
September 22, 2025
The pharmaceutical landscape is currently a tale of two giants employing vastly different, yet highly successful, growth strategies. Eli Lilly and Company (NYSE: LLY) has placed an extraordinary bet on...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Merck Snags A Key Approval Before Its Cash Cow Goes Off A Patent Cliff
↗
September 22, 2025
But that doesn't mean Keytruda is safe from the looming patent cliff.
Via
Investor's Business Daily
Topics
Intellectual Property
3 Dirt-Cheap Stocks to Buy Right Now
↗
September 22, 2025
These stocks share several common denominators, including attractive valuations.
Via
The Motley Fool
Topics
Intellectual Property
What Is Considered a Good Stock Dividend? 3 Healthcare Stocks That Fit the Bill
↗
September 20, 2025
A high yield is only one part of the story when it comes to picking dividend stocks.
Via
The Motley Fool
Topics
Intellectual Property
FDA Approves Merck’s KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph) Injection for Subcutaneous Use in Adults Across Most Solid Tumor Indications for KEYTRUDA® (pembrolizumab)
September 19, 2025
From
Merck & Co., Inc.
Via
Business Wire
Merck Scores Positive Feedback From EU Agency Regarding Blockbuster Cancer Drug
↗
September 19, 2025
Merck received positive Keytruda notes from CHMP regarding its breakthrough cancer treatment with final decisions expected in late 2025.
Via
Benzinga
Lilly's Oncology Momentum Soars: Olomorasib Gains Breakthrough Status, Jaypirca Achieves Landmark Clinical Successes
September 19, 2025
Eli Lilly and Company (NYSE: LLY) is making significant waves in the oncology landscape with a series of major announcements concerning two of its innovative cancer therapies: Olomorasib and Jaypirca...
Via
MarketMinute
Decoding Merck & Co's Options Activity: What's the Big Picture?
↗
September 19, 2025
Via
Benzinga
Merck Receives Positive EU CHMP Opinion for ENFLONSIA™ (clesrovimab) for the Prevention of Respiratory Syncytial Virus (RSV) in Infants During Their First RSV Season
September 19, 2025
From
Merck & Co., Inc.
Via
Business Wire
Merck Receives Two Positive EU CHMP Opinions for KEYTRUDA® (pembrolizumab), for Subcutaneous (SC) Administration and for New Indication for Earlier-Stage Head and Neck Cancer
September 19, 2025
From
Merck & Co., Inc.
Via
Business Wire
Elizabeth Warren Says Measles Can Hit Record Highs, Slams RFK Jr.'s CDC Panel For Delaying Vaccine: 'How Does That Keep Our Kids Safe?'
↗
September 18, 2025
Sen. Elizabeth Warren (D-Mass.) on Thursday criticized the Centers for Disease Control and Prevention's vaccine advisory panel following its controversial vote to delay the combined measles, mumps,...
Via
Benzinga
Advancing Cancer Research Brings New Hope for Patients Worldwide
September 17, 2025
Via
Investor Brand Network
Topics
Artificial Intelligence
Intellectual Property
Advancing Cancer Research Brings New Hope for Patients Worldwide
September 17, 2025
EQNX::TICKER_START (OTCQB:OTLC),(NASDAQ:IOVA),(NYSE:MRK),(NASDAQ:AZN),(NYSE:BMY) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Intellectual Property
Robert Kennedy Jr. Packs CDC Panel With Vaccine Skeptics Ahead of Key Vote On COVID-19 Shots
↗
September 15, 2025
Health and Human Services Secretary Robert F. Kennedy Jr. has added five new members to the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices, just days...
Via
Benzinga
The Weight of Progress: A New Era Dawns for Anti-Obesity Drugs, Reshaping Markets and Health
September 15, 2025
The global anti-obesity drug market is experiencing an unprecedented surge, driven by groundbreaking advancements in pharmacotherapy, particularly the advent of highly effective GLP-1 receptor...
Via
MarketMinute
Merck & Co. Inc. (NYSE:MRK): A Prime Value Stock with Strong Profitability and Sound Finances
↗
September 15, 2025
Discover Merck & Co. (MRK), a top value stock with strong profitability, sound financial health, and an attractive valuation. A prime pick for value investors.
Via
Chartmill
Raludotatug Deruxtecan Granted Breakthrough Therapy Designation by U.S. FDA for Patients with CDH6 Expressing Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancers Previously Treated with Bevacizumab
September 15, 2025
From
Daiichi Sankyo
Via
Business Wire
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
